Latest Financials News

Vital Metals has unveiled a promising Scoping Study for its Tardiff Rare Earth and Niobium project in Canada, highlighting strong financial metrics and significant growth potential over an 11-year mine life.

Diablo Resources Limited reported a cash outflow for the June 2025 quarter, with limited cash reserves and plans underway to secure additional funding to sustain its exploration activities.

Diablo Resources advances exploration at its Phoenix Copper Project with significant rock sampling results and drill permits granted for key prospects, setting the stage for drilling in Q3 2025.

Platformo Ltd’s Biztrak business reported a robust 41% revenue increase in the June 2025 quarter, driven by software enhancements and training tied to Malaysia’s evolving e-invoicing regulations. The company also tightened cost controls, reducing net cash outflow while preparing for upcoming compliance deadlines.

Saferoads Holdings reports a $192k operating cash use impacted by strategic prepayments, completes its Road Safety Rentals asset sale, and maintains strong cash reserves after paying a substantial dividend.

Trek Metals has accelerated its exploration at the Christmas Creek Project with expanded drilling revealing promising high-grade gold mineralisation and a newly discovered gold nugget field. Backed by a $3.5 million capital raise and government co-funding, the company is poised for further breakthroughs.

Chariot Corporation has secured a 66.7% stake in one of Nigeria’s largest hard-rock lithium portfolios, backed by a A$1.6 million capital raise and a new working capital facility, marking a strategic move into the Africa–China lithium corridor.

Sandon Capital Investments announces a fully franked 1.4 cent dividend for the September quarter, reflecting robust FY2025 portfolio returns and a healthy dividend yield.

Ioneer Ltd has dramatically expanded its lithium-boron Ore Reserves at Rhyolite Ridge, reinforcing the project’s robust economics and securing $16 million in new funding to advance development.

TruScreen Group Limited has announced a placement of over 1.7 million shares to settle marketing invoices and provide an equity incentive to its CFO, signaling strategic capital management ahead of its next growth phase.

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.